Our Clinical Trials

Grounded in Science and born of boundless curiosity, EMD Serono’s clinical trials have enrolled thousands globally to change the cancer care landscape.

FEATURED CLINICAL PROGRAMS

TARGETING MET clinical trials now enrolling

Targeting MET

Are you interested in learning more about a clinical trial program investigating the inhibition of oncogenic signaling caused by MET (gene) alterations?

LEARN MORE ABOUT OUR CLINICAL TRIALS
DDRiver clinical trial program

DDRiver

Are you interested in learning more about a clinical trial program investigating the potential anticancer effect of inhibiting the DNA damage response (DDR) pathway?

LEARN MORE ABOUT OUR CLINICAL TRIALS
DDRiver clinical trial program

TrilynX

Are you interested in learning more about a clinical trial investigating the potential to enhance the activity of definitive therapy for LA SCCHN through antagonism of Inhibitor of Apoptosis Proteins (IAP)?

LEARN MORE ABOUT THIS CLINICAL TRIAL

Abbreviations:
LA SCCHN, locally advanced squamous cell carcinoma of the head and neck; MET, mesenchymal epithelial transition factor.

Are You a Healthcare Professional?

Yes No